Neogen (NEOG)
Neogen on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, financials, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as in vitro & in vivo diagnostic substances.
11.8M
Short interest
settlement 2026-09-30
2.0
Days to cover
-2.5 days vs prior
68.7%
Short share of volume
2026-10-12
1,791
Fails to deliver
settlement 2026-09-14
Thu 7 Jan
Next earnings
estimated date
$10K
Insider flow, 90 days
2 buys, 0 sells
As of 2026-10-12.
Short interest
FINRA, twice a month. The newest 24 settlements in the table, 48 in the chart. JSONAs of 30 September 2026, short interest in NEOG is 11,846,307 shares, up 1,264,122 shares over the last month. Over the last 48 readings it ranged from 9,024,290 shares (13 March 2026) to 27,163,993 shares (15 May 2025). At the reported average volume of 5.8M shares a day that is 2.0 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/neog" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-09-30 | 11,846,307 | +6.1% | 5,825,645 | 2.03 |
| 2026-09-15 | 11,168,684 | +5.5% | 2,463,422 | 4.53 |
| 2026-08-31 | 10,582,185 | +6.5% | 1,428,086 | 7.41 |
| 2026-08-14 | 9,933,588 | +5.3% | 2,346,618 | 4.23 |
| 2026-07-31 | 9,434,693 | -12.5% | 2,174,850 | 4.34 |
| 2026-07-15 | 10,786,299 | +2.8% | 1,434,286 | 7.52 |
| 2026-06-30 | 10,491,465 | -12.0% | 2,570,502 | 4.08 |
| 2026-06-15 | 11,920,395 | -8.6% | 1,853,454 | 6.43 |
| 2026-05-29 | 13,034,627 | +21.5% | 3,608,893 | 3.61 |
| 2026-05-15 | 10,730,309 | -3.3% | 1,853,947 | 5.79 |
| 2026-04-30 | 11,093,945 | +10.6% | 2,368,008 | 4.68 |
| 2026-04-15 | 10,029,164 | -0.4% | 3,312,010 | 3.03 |
| 2026-03-31 | 10,069,503 | +11.6% | 2,320,321 | 4.34 |
| 2026-03-13 | 9,024,290 | -8.9% | 2,877,406 | 3.14 |
| 2026-02-27 | 9,906,307 | -5.3% | 2,367,714 | 4.18 |
| 2026-02-13 | 10,456,064 | -11.9% | 3,285,388 | 3.18 |
| 2026-01-30 | 11,865,302 | -15.8% | 3,196,788 | 3.71 |
| 2026-01-15 | 14,099,129 | -17.6% | 6,000,603 | 2.35 |
| 2025-12-31 | 17,105,312 | -15.7% | 2,474,340 | 6.91 |
| 2025-12-15 | 20,301,078 | -0.2% | 4,492,243 | 4.52 |
| 2025-11-28 | 20,342,079 | -2.4% | 4,041,611 | 5.03 |
| 2025-11-14 | 20,834,267 | -10.0% | 3,041,319 | 6.85 |
| 2025-10-31 | 23,141,526 | +0.9% | 3,341,059 | 6.93 |
| 2025-10-15 | 22,932,941 | -2.2% | 6,341,234 | 3.62 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 12 October 2026, the short share of NEOG volume is 68.7%, up 0.3 points over the last five sessions. Over the last 30 readings it ranged from 30.0% (24 September 2026) to 86.6% (9 October 2026). The latest reading is 4.7 points above the 30-session average of 63.9%, on 844K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-10-12 | 580K | 844K | 68.7% | 0 |
| 2026-10-09 | 762K | 881K | 86.6% | 163 |
| 2026-10-08 | 2.2M | 3.0M | 75.0% | 197 |
| 2026-10-07 | 4.3M | 5.3M | 82.0% | 3,461 |
| 2026-10-06 | 1.3M | 1.9M | 68.7% | 1 |
| 2026-10-05 | 943K | 1.4M | 68.3% | 0 |
| 2026-10-02 | 449K | 822K | 54.6% | 0 |
| 2026-10-01 | 538K | 1.1M | 50.5% | 600 |
| 2026-09-30 | 850K | 1.4M | 62.6% | 1 |
| 2026-09-29 | 1.5M | 3.5M | 43.4% | 1,101 |
| 2026-09-28 | 1.3M | 1.6M | 82.9% | 0 |
| 2026-09-25 | 1.1M | 2.8M | 38.5% | 19,675 |
| 2026-09-24 | 578K | 1.9M | 30.0% | 0 |
| 2026-09-23 | 699K | 1.3M | 55.1% | 220 |
| 2026-09-22 | 1.3M | 1.9M | 65.8% | 13,730 |
| 2026-09-21 | 1.0M | 1.6M | 63.0% | 1,293 |
| 2026-09-18 | 738K | 980K | 75.3% | 47 |
| 2026-09-17 | 826K | 1.1M | 75.2% | 3 |
| 2026-09-16 | 758K | 1.1M | 71.1% | 2,700 |
| 2026-09-15 | 575K | 1.4M | 41.3% | 0 |
| 2026-09-14 | 372K | 564K | 66.0% | 0 |
| 2026-09-11 | 332K | 446K | 74.3% | 0 |
| 2026-09-10 | 350K | 485K | 72.1% | 0 |
| 2026-09-09 | 986K | 2.8M | 35.2% | 0 |
| 2026-09-08 | 539K | 789K | 68.3% | 200 |
| 2026-09-04 | 184K | 343K | 53.7% | 0 |
| 2026-09-03 | 283K | 422K | 67.2% | 0 |
| 2026-09-02 | 488K | 647K | 75.4% | 0 |
| 2026-09-01 | 322K | 466K | 69.0% | 0 |
| 2026-08-31 | 262K | 335K | 78.3% | 0 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 14 September 2026, the fails-to-deliver balance in NEOG is 1,791 shares, up 835 shares over the last settlement date. Over the last 30 readings it ranged from 3 shares (17 March 2026) to 55,546 shares (24 August 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-09-14 | 1,791 | $11.78 | $21K |
| 2026-08-28 | 956 | $11.74 | $11K |
| 2026-08-24 | 55,546 | $11.95 | $664K |
| 2026-08-07 | 3,251 | $11.30 | $37K |
| 2026-08-04 | 7,788 | $11.90 | $93K |
| 2026-07-16 | 7,804 | $9.98 | $78K |
| 2026-07-10 | 41,083 | $9.75 | $401K |
| 2026-06-26 | 64 | $9.51 | $609 |
| 2026-06-15 | 2,620 | $9.10 | $24K |
| 2026-06-08 | 15 | $8.90 | $134 |
| 2026-05-20 | 8,291 | $8.35 | $69K |
| 2026-05-14 | 910 | $8.69 | $8K |
| 2026-05-13 | 7,878 | $8.61 | $68K |
| 2026-05-12 | 8,188 | $8.65 | $71K |
| 2026-05-07 | 3 | $9.18 | $28 |
| 2026-04-28 | 5 | $9.45 | $47 |
| 2026-04-27 | 71 | $9.54 | $677 |
| 2026-04-24 | 704 | $9.35 | $7K |
| 2026-04-13 | 497 | $9.42 | $5K |
| 2026-04-10 | 497 | $10.04 | $5K |
| 2026-03-20 | 241 | $8.70 | $2K |
| 2026-03-17 | 3 | $9.11 | $27 |
| 2026-03-11 | 35 | $9.65 | $338 |
| 2026-03-10 | 10,306 | $9.70 | $100K |
| 2026-03-09 | 391 | $9.70 | $4K |
| 2026-03-04 | 17 | $10.90 | $185 |
| 2026-03-03 | 51,587 | $11.15 | $575K |
| 2026-02-24 | 18 | $11.09 | $200 |
| 2026-02-23 | 18 | $11.33 | $204 |
| 2026-02-13 | 40,359 | $10.78 | $435K |
Insider trades
SEC Form 4, newest first, 50 of 100 shown. JSONInsiders at NEOG reported 2 open-market buys worth $10K in the last 90 days and no open-market sells. Latest filing: Nassif Mikheal (CEO) on 2026-10-09.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-10-09 | Nassif Mikheal | CEO | Buy | 505 | $11.95 | $6K | 2K |
| 2026-10-01 | Wainer Andrea F | Director | Grant | 10K | $12.24 | $120K | 12K |
| 2026-10-01 | RODRIGUEZ RAFAEL A | Director | Grant | 10K | $12.24 | $120K | 31K |
| 2026-10-01 | Pelossof Avi | Director | Grant | 10K | $12.24 | $120K | 10K |
| 2026-10-01 | Gupta Aashima | Director | Grant | 10K | $12.24 | $120K | 38K |
| 2026-10-01 | Woteki Catherine E | Director | Grant | 10K | $12.24 | $120K | 29K |
| 2026-10-01 | Green Ronald D | Director | Grant | 10K | $12.24 | $120K | 28K |
| 2026-10-01 | BOREL JAMES C | Director | Grant | 10K | $12.24 | $120K | 106K |
| 2026-10-01 | CAPELLO JEFFREY D | Director | Grant | 10K | $12.24 | $120K | 42K |
| 2026-08-19 | Nassif Mikheal | CEO | Tax withholding | 20K | $11.87 | $242K | 26K |
| 2026-08-19 | Moylan John Patrick | Chief Accounting Officer | Tax withholding | 2K | $11.87 | $28K | 29K |
| 2026-08-14 | Ranalli Tamara A. | Senior Vice President | Grant | 26K | $11.65 | $300K | 26K |
| 2026-08-14 | Stacey Jennifer Evans | Chief Legal Officer | Grant | 39K | $11.65 | $450K | 39K |
| 2026-08-14 | Riggsbee Richard Bryan | CFO | Grant | 52K | $11.65 | $600K | 52K |
| 2026-08-14 | Nassif Mikheal | CEO | Grant | 142K | $11.65 | $1.7M | 142K |
| 2026-08-14 | Moylan John Patrick | Chief Accounting Officer | Grant | 9K | $11.65 | $100K | 32K |
| 2026-08-04 | Nassif Mikheal | CEO | Buy | 370 | $11.81 | $4K | 1K |
| 2026-06-03 | Moylan John Patrick | Chief Accounting Officer | Tax withholding | 3K | $8.75 | $22K | 24K |
| 2026-05-18 | Rocklin Amy M | Former Chief Legal Officer | Tax withholding | 10K | $9.29 | $95K | 82K |
| 2026-05-18 | Rocklin Amy M | Former Chief Legal Officer | Option exercise | 35K | $9.29 | $327K | 92K |
| 2026-05-04 | Moylan John Patrick | Chief Accounting Officer | Tax withholding | 2K | $9.53 | $15K | 17K |
| 2026-05-04 | Moylan John Patrick | Chief Accounting Officer | Option exercise | 5K | $9.53 | $43K | 19K |
| 2026-05-01 | Stacey Jennifer Evans | Chief Legal Officer | Grant | 39K | $9.53 | $375K | 39K |
| 2026-02-17 | Nassif Mikheal | CEO | Buy | 23 | $10.94 | $252 | 704 |
| 2026-02-02 | Nassif Mikheal | CEO | Buy | 24 | $10.00 | $240 | 681 |
| 2026-01-26 | Nassif Mikheal | CEO | Buy | 25 | $9.86 | $246 | 657 |
| 2026-01-16 | Nassif Mikheal | CEO | Buy | 137 | $9.33 | $1K | 632 |
| 2026-01-07 | Ranalli Tamara A. | Senior Vice President | Grant | 51K | $7.38 | $375K | 51K |
| 2025-12-01 | Naemura David H. | Former CFO | Tax withholding | 4K | $5.98 | $21K | 90K |
| 2025-12-01 | Naemura David H. | Former CFO | Option exercise | 13K | $5.98 | $77K | 94K |
| 2025-11-03 | Riggsbee Richard Bryan | CFO | Grant | 179K | $6.29 | $1.1M | 179K |
| 2025-11-03 | Nassif Mikheal | CEO | Buy | 177 | $6.25 | $1K | 495 |
| 2025-10-27 | RODRIGUEZ RAFAEL A | Director | Option exercise | 2K | $6.19 | $11K | 21K |
| 2025-10-27 | Tobin James P | Director | Option exercise | 2K | $6.19 | $11K | 43K |
| 2025-10-27 | Woteki Catherine E | Director | Option exercise | 2K | $6.19 | $11K | 19K |
| 2025-10-27 | Rocklin Amy M | Chief Legal Officer | Tax withholding | 2K | $6.19 | $13K | 57K |
| 2025-10-27 | Rocklin Amy M | Chief Legal Officer | Option exercise | 9K | $6.19 | $59K | 59K |
| 2025-10-27 | Naemura David H. | Chief Financial Officer | Tax withholding | 4K | $6.19 | $26K | 81K |
| 2025-10-27 | Naemura David H. | Chief Financial Officer | Option exercise | 16K | $6.19 | $96K | 85K |
| 2025-10-27 | Jones Douglas Edward | Former COO | Tax withholding | 3K | $6.19 | $22K | 101K |
| 2025-10-27 | Jones Douglas Edward | Former COO | Option exercise | 16K | $6.19 | $96K | 104K |
| 2025-10-27 | CAPELLO JEFFREY D | Director | Option exercise | 2K | $6.19 | $13K | 31K |
| 2025-10-27 | BOREL JAMES C | Director | Option exercise | 2K | $6.19 | $13K | 95K |
| 2025-10-27 | BOEHM WILLIAM T | Director | Option exercise | 4K | $6.07 | $22K | 48K |
| 2025-10-27 | ADENT JOHN EDWARD | Former CEO | Tax withholding | 9K | $6.19 | $53K | 363K |
| 2025-10-27 | ADENT JOHN EDWARD | Former CEO | Option exercise | 39K | $6.19 | $240K | 372K |
| 2025-10-27 | Gupta Aashima | Director | Option exercise | 2K | $6.19 | $11K | 28K |
| 2025-10-27 | Green Ronald D | Director | Option exercise | 2K | $6.19 | $11K | 19K |
| 2025-10-27 | CAPELLO JEFFREY D | Director | Option exercise | 2K | $6.19 | $11K | 33K |
| 2025-10-27 | BOREL JAMES C | Director | Option exercise | 2K | $6.19 | $11K | 96K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Planned sales (Form 144)
Newest first. JSON2 Form 144 notices on file for NEOG worth $1.1M at the prices reported; 0 in the last 90 days worth $0. Latest: Rocklin Amy M filed on 2026-06-03 to sell 30,337 shares ($267K) from 2026-06-03.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-06-03 | Rocklin Amy MFormer Officer | 30K | $267K | 0.014% | 2026-06-03 | Fidelity Brokerage Services LLC |
| 2026-05-29 | Rocklin Amy MFormer Officer | 88K | $805K | 0.040% | 2026-05-29 | Fidelity Brokerage Services LLC |
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON6 holders report 5% or more of NEOG in their latest filing, all on Schedule 13G (passive). The largest reported stake is Neuberger Berman Group LLC at 7.6% of the class (16,570,795 shares), filed 2026-07-07 for an event on 2026-06-30.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-07-07 | 13G | Neuberger Berman Group LLCparent holding company | 16.6M | 7.6% | 2026-06-30 |
| 2026-07-07 | 13G | Neuberger Berman Investment Advisers LLCinvestment adviser | 16.1M | 7.4% | 2026-06-30 |
| 2026-05-14 | 13G/Ano. 2 | Clarkston Capital Partners, LLCinvestment adviser | 2.2M | 1.0% | 2026-03-31 |
| 2026-05-14 | 13G/Ano. 2 | Clarkston Companies, Inc.parent holding company, corporation | 2.2M | 1.0% | 2026-03-31 |
| 2026-05-14 | 13G/Ano. 2 | Jeffrey A. Hakalaparent holding company, individual | 2.2M | 1.0% | 2026-03-31 |
| 2026-05-14 | 13G/Ano. 2 | Gerald W. Hakalaparent holding company, individual | 2.2M | 1.0% | 2026-03-31 |
| 2026-04-30 | 13G | Vanguard Capital Managementinvestment adviser | 11.2M | 5.1% | 2026-03-31 |
| 2026-04-29 | 13G | Vanguard Portfolio Managementinvestment adviser | 12.9M | 5.9% | 2026-03-31 |
| 2026-03-27 | 13G/Ano. 15 | The Vanguard Groupinvestment adviser | 0 | 0.0% | 2026-03-13 |
| 2026-02-17 | 13G/Ano. 1 | Gates Capital Management, L.P.investment adviser, partnership | 8.4M | 3.9% | 2025-12-31 |
| 2026-02-17 | 13G/Ano. 1 | Gates Capital Management GP, LLCother entity | 8.4M | 3.9% | 2025-12-31 |
| 2026-02-17 | 13G/Ano. 1 | Gates Capital Management, Inc.investment adviser, corporation | 8.4M | 3.9% | 2025-12-31 |
| 2026-02-17 | 13G/Ano. 1 | Jeffrey L. Gatesindividual | 8.4M | 3.9% | 2025-12-31 |
| 2025-12-04 | 13G/Ano. 1 | ING GROEP NVparent holding company | 8.7M | 4.0% | 2025-11-28 |
| 2025-12-04 | 13G/Ano. 1 | ING Capital Markets LLCother entity | 8.7M | 4.0% | 2025-11-28 |
| 2025-11-13 | 13G/Ano. 1 | Modell Capital LLCparent holding company, other entity | 11.7M | 5.4% | 2025-09-30 |
| 2025-11-13 | 13G/Ano. 1 | Jeremy J. Modellparent holding company, individual | 11.7M | 5.4% | 2025-09-30 |
13F holders
Tracked managers holding NEOG at their latest 13F. JSON4 of the 30 tracked managers held NEOG at their latest 13F, $6.7M in total at quarter-end prices. AQR Capital Management is the largest at $4.5M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 2 added shares and 2 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| AQR Capital Management | 2026-06-30 | 500K | $4.5M | 0.00% | -90K |
| Renaissance Technologies | 2026-06-30 | 118K | $1.1M | 0.00% | new |
| Citadel Advisors | 2026-06-30 | 86K | $772K | 0.00% | -913K |
| D. E. Shaw & Co. | 2026-06-30 | 42K | $382K | 0.00% | new |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
Financials
SEC XBRL, as filed. JSONIn Q1 FY 2027 (quarter ended 2026-08-31) Neogen reported revenue of $222.8M, up 6.5% from the same quarter a year earlier, and net loss of $11.9M (-0.05 diluted EPS). In FY 2026 it generated $83.2M of operating cash flow. As of 2026-08-31, cash was $172.0M against $774.2M of debt.
- Cash
- $172.0M
- Debt
- $774.2M
- Equity
- $2.09B
- Total assets
- $3.30B
- Shares outstanding
- 218,306,034
Quarterly, last 8 quarters
| Quarter | Period end | Revenue | Net income | Margin | Diluted EPS |
|---|---|---|---|---|---|
| Q1 FY 2027 | 2026-08-31 | $222.8M | -$11.9M | -5.3% | -0.05 |
| Q4 FY 2026derived | 2026-05-31 | $225.3M | -$11.3M | -5.0% | n/a |
| Q3 FY 2026 | 2026-02-28 | $211.2M | -$17.0M | -8.0% | -0.08 |
| Q2 FY 2026 | 2025-11-30 | $224.7M | -$15.9M | -7.1% | -0.07 |
| Q1 FY 2026 | 2025-08-31 | $209.2M | $36.3M | 17.4% | 0.17 |
| Q4 FY 2025derived | 2025-05-31 | $225.5M | -$612.2M | -271.5% | n/a |
| Q3 FY 2025 | 2025-02-28 | $221.0M | -$10.9M | -4.9% | -0.05 |
| Q2 FY 2025 | 2024-11-30 | $231.3M | -$456.3M | -197.3% | -2.10 |
Fiscal years, with buybacks and dividends
| Fiscal year | Ends | Revenue | Net income | Operating cash flow | Capex | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| FY 2026 | 2026-05-31 | $870.4M | -$7.9M | $83.2M | $51.3M | n/a | n/a |
| FY 2025 | 2025-05-31 | $894.7M | -$1.09B | $58.2M | $104.6M | n/a | n/a |
| FY 2024 | 2024-05-31 | $924.2M | -$9.4M | $35.3M | $111.4M | n/a | n/a |
| FY 2023 | 2023-05-31 | $822.4M | -$22.9M | $41.0M | $65.8M | n/a | n/a |
| FY 2022 | 2022-05-31 | $527.2M | $48.3M | $68.0M | $24.4M | n/a | n/a |
Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are the cash the company paid to repurchase its common stock in the year, not the amount authorized. Balance sheet lines are as of 2026-08-31; shares outstanding as of 2026-08-31 from the cover page.
What this page is
Neogen in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows Neogen (NEOG), SEC CIK 711377, listed on Nasdaq, classified by the SEC as in vitro & in vivo diagnostic substances. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-09-30.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-10-12.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-09-14.JSON and CSV
- Planned sales
- SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-06-03.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-07-07.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Financials
- SEC EDGAR 10-K and 10-Q filingsSource: SEC.Weekly; values are as filed in the 10-Q and 10-K. Latest 2026-08-31.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-10-06.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-10-09.JSON and CSV
- Company record
- EDGAR filing index for CIK 711377Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as in vitro & in vivo diagnostic substances
Other company pages
Datasets
Frequently Asked Questions
How much of NEOG is sold short?
What is NEOG's daily short volume?
Does NEOG have fails to deliver?
Are NEOG insiders buying or selling?
Have NEOG insiders filed to sell?
Who owns 5% or more of NEOG?
What did NEOG report last quarter?
Which tracked 13F managers own NEOG?
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.